Press Release – New York, NY – January 8, 2026 – Sichenzia Ross Ference Carmel LLP announced today that it represented Aegis Capital Corp., as exclusive placement agent, in connection with a recent $8 million registered direct offering and concurrent private placement of Estrella Immunopharma, Inc. (Nasdaq: ESLA), a clinical-stage biopharmaceutical company.
The SRFC team was led by partners Darrin M. Ocasio, Marcelle Balcombe and Philip Magri, with associate Ronghong Dai.